Goldman Sachs Initiates Coverage On AstraZeneca With Buy Rating, Announces Price Target of $97
Goldman Sachs Initiates Coverage On AstraZeneca With Buy Rating, Announces Price Target of $97
高盛以買入評級啓動對阿斯利康的報道,宣佈目標股價爲97美元
Goldman Sachs analyst Rajan Sharma initiates coverage on AstraZeneca (NASDAQ:AZN) with a Buy rating and announces Price Target of $97.
高盛分析師拉詹·夏爾馬開始對阿斯利康(納斯達克股票代碼:AZN)進行報道,評級爲買入,並宣佈目標股價爲97美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。